[DPHARMA] QoQ Cumulative Quarter Result on 30-Sep-2013 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
19-Nov-2013
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2013
Quarter
30-Sep-2013 [#3]
Profit Trend
QoQ- 39.03%
YoY- 20.77%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 81,118 40,495 162,405 116,671 75,826 37,837 135,310 -28.96%
PBT 21,302 11,175 40,175 31,017 21,963 8,956 35,298 -28.65%
Tax -5,410 -2,810 -7,900 -6,842 -4,575 -2,257 -9,284 -30.30%
NP 15,892 8,365 32,275 24,175 17,388 6,699 26,014 -28.06%
-
NP to SH 15,892 8,365 32,275 24,175 17,388 6,699 26,014 -28.06%
-
Tax Rate 25.40% 25.15% 19.66% 22.06% 20.83% 25.20% 26.30% -
Total Cost 65,226 32,130 130,130 92,496 58,438 31,138 109,296 -29.18%
-
Net Worth 179,045 190,050 181,850 179,125 187,340 176,143 169,354 3.78%
Dividend
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Div 5,551 - 24,293 - 5,550 - 19,434 -56.72%
Div Payout % 34.93% - 75.27% - 31.92% - 74.71% -
Equity
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Net Worth 179,045 190,050 181,850 179,125 187,340 176,143 169,354 3.78%
NOSH 138,794 138,723 138,817 138,856 138,770 138,695 138,815 -0.01%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin 19.59% 20.66% 19.87% 20.72% 22.93% 17.70% 19.23% -
ROE 8.88% 4.40% 17.75% 13.50% 9.28% 3.80% 15.36% -
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 58.44 29.19 116.99 84.02 54.64 27.28 97.47 -28.96%
EPS 11.45 6.03 23.25 17.41 12.53 4.83 18.74 -28.06%
DPS 4.00 0.00 17.50 0.00 4.00 0.00 14.00 -56.71%
NAPS 1.29 1.37 1.31 1.29 1.35 1.27 1.22 3.80%
Adjusted Per Share Value based on latest NOSH - 138,773
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
RPS 8.43 4.21 16.88 12.13 7.88 3.93 14.07 -28.99%
EPS 1.65 0.87 3.36 2.51 1.81 0.70 2.70 -28.05%
DPS 0.58 0.00 2.53 0.00 0.58 0.00 2.02 -56.57%
NAPS 0.1861 0.1976 0.189 0.1862 0.1948 0.1831 0.1761 3.76%
Price Multiplier on Financial Quarter End Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 30/06/14 31/03/14 31/12/13 30/09/13 28/06/13 29/03/13 31/12/12 -
Price 2.97 3.03 2.58 2.55 2.38 2.23 2.13 -
P/RPS 5.08 10.38 2.21 3.03 4.36 8.17 2.19 75.50%
P/EPS 25.94 50.25 11.10 14.65 18.99 46.17 11.37 73.56%
EY 3.86 1.99 9.01 6.83 5.26 2.17 8.80 -42.35%
DY 1.35 0.00 6.78 0.00 1.68 0.00 6.57 -65.27%
P/NAPS 2.30 2.21 1.97 1.98 1.76 1.76 1.75 20.04%
Price Multiplier on Announcement Date
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Date 26/08/14 20/05/14 26/02/14 19/11/13 28/08/13 27/05/13 25/02/13 -
Price 3.37 3.09 2.60 2.56 2.44 2.51 2.17 -
P/RPS 5.77 10.59 2.22 3.05 4.47 9.20 2.23 88.80%
P/EPS 29.43 51.24 11.18 14.70 19.47 51.97 11.58 86.55%
EY 3.40 1.95 8.94 6.80 5.14 1.92 8.64 -46.39%
DY 1.19 0.00 6.73 0.00 1.64 0.00 6.45 -67.69%
P/NAPS 2.61 2.26 1.98 1.98 1.81 1.98 1.78 29.15%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment